August 13, 2012 – The “electronic nose” or “e-nose” was developed to detect hazardous gases that go unnoticed by the human nose. For example, e-noses have been used to protect astronauts from harmful chemicals in space. In a commercial setting, an “electronic nose” is used as a “spoilage detector” in the food and wine industry.
Now, Australian researchers have modified an electronic nose to diagnose and differentiate between benign and malignant mesothelioma. A team of researchers from the University of New South Wales developed a diagnostic breath test using an e-nose that analyzes and compares exhaled breathing. The clinical study results were recently published in the European Respiratory Journal.
Electronic Nose or E-Nose Allows for Early, Non-Invasive Diagnosis of Mesothelioma
The research team in Australia modified the electronic nose with a carbon polymer array to sniff out the chemical differences in exhaled breathing. When we exhale, we release volatile organic compounds. Mesothelioma patients induce a different particle compound in their exhaled breaths and the breath test has the ability to differentiate between benign and malignant mesothelioma.
Early detection of malignant mesothelioma is vital in patient treatment and survival rates. Symptoms of mesothelioma are hard to identify and can take well over twenty years to surface. By the time patients experience the symptoms, the cancer is in the advanced stages. The e-nose can be used as an effective screening tool, revealing mesothelioma in its early stages. In addition, this diagnostic test is non-invasive and simple to administer to the elderly, the most common victims of mesothelioma.
If you or a family member is suffering from the devastating effects of asbestos exposure, contact the Shein Law to speak with an experienced, knowledgeable mesothelioma lawyer. Our Philadelphia attorneys are dedicated to serving victims of asbestos-related illnesses and their families and getting the maximum compensation for your losses. For a free consultation call 1-877-SHEINLAW (1-877-743-4652) or contact us online.